Scientists at UW-Madison say they may be within two or three years of human trials on a promising stem-cell treatment for the deadly nerve disease amyotrophic lateral sclerosis or ALS.
In an article published Tuesday in the journal Human Gene Therapy, researchers reported they have injected ALS- afflicted rats with human nerve stem cells that flourished in the animals’ diseased spinal cords.